MARC details
000 -LEADER |
fixed length control field |
04534cam a22005417i 4500 |
001 - CONTROL NUMBER |
control field |
17692510 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20210930191537.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
130410s2013 enka b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2013937641 |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
101619755 |
Source |
DNLM |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
016073421 |
Source |
Uk |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781907568787 (print) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1907568786 (print) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Canceled/invalid ISBN |
9781908818409 (online) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)ocn745979945 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Language of cataloging |
eng |
Transcribing agency |
NLM |
Description conventions |
rda |
Modifying agency |
BTCTA |
-- |
YDXCP |
-- |
UKMGB |
-- |
CDX |
-- |
EYM |
-- |
UUM |
-- |
BDX |
-- |
OCLCO |
-- |
OCLCF |
-- |
U3G |
-- |
VRC |
-- |
N5L |
-- |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
nlmcopyc |
-- |
lccopycat |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
HD9665.5 |
Item number |
.S58 2013 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
2013 J-232 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 55 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1/900685 |
Edition number |
23 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Smart, Nigel J., |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Lean biomanufacturing : |
Remainder of title |
creating value through innovative bioprocessing approaches / |
Statement of responsibility, etc. |
Nigel J. Smart. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Oxford ; |
-- |
Philadelphia : |
Name of producer, publisher, distributor, manufacturer |
Woodhead Publishing, |
Date of production, publication, distribution, manufacture, or copyright notice |
2013. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxvii, 355 pages : |
Other physical details |
illustrations ; |
Dimensions |
25 cm. |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Source |
rdacarrier |
490 1# - SERIES STATEMENT |
Series statement |
Woodhead Publishing series in biomedicine, |
International Standard Serial Number |
2050-0289 ; |
Volume/sequential designation |
number 37 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
1. An introduction to Lean biomanufacturing -- 2. Lean technologies/methods to be applied to biomanufacturing -- 3. Creation, execution and implementation of the Transition Plan -- 4. Issues and problems for the biopharmaceutical industry that make the situation challenging -- 5. Developing a Lean approach to biopharmaceutical processes -- 6. The contribution of simulation models in the development of Lean biopharmaceutical processes -- 7. Integration of biomanufacturing with Lean laboratory operations -- 8. Lean compliance and considerations connected with enabling Lean manufacturing -- 9. Ready to use technologies and their role in Lean biomanufacturing. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
With decreasing profit margins, increasing cost pressures, growing regulatory compliance concerns, mounting pressure from generic drugs and increasing anxiety about the future of healthcare reimbursement, pharmaceutical manufacturers are now forced to re-examine and re-assess the way they have been doing things. In order to sustain profitability, these companies are looking to reduce waste (of all kinds), improve efficiency and increase productivity. Many of them are taking a closer look at lean manufacturing as a way to achieve these goals. Lean biomanufacturing re-visits lean principles and then applies them sympathetically - in a highly practical approach - to the specific needs of pharmaceutical processes, which present significantly different challenges to more mainstream manufacturing processes. A major goal of the book is to highlight those problems and issues that appear more specific or unique to biopharmaceutical manufacturing situations and to provide some insights into what challenges are the important ones to solve and what techniques, tools and mechanisms to employ to be successful. Following an introduction to lean biomanufacturing, the book goes on to discuss lean technologies and methods applied in biomanufacturing. Later chapters cover the creation and implementation of the Transition Plan, issues facing the biopharmaceutical industry, creating a lean approach towards biopharmaceutical processes and the contribution of simulation models in developing these processes. The final chapter covers examples of new technology innovations which help facilitate lean biomanufacturing. A focus on the issues associated with the application of lean principles to biomanufacturingPractical examples of factors which can affect biopharmaceutical processesCoverage of key factors which require integration to run an efficient biopharmaceutical process.-- |
Assigning source |
Source other than Library of Congress. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical industry. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Research. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Prices. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical Preparations. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biopharmaceutics. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biotechnology |
General subdivision |
methods. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Prices. |
Source of heading or term |
fast |
Authority record control number or standard number |
(OCoLC)fst00898879 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Research. |
Source of heading or term |
fast |
Authority record control number or standard number |
(OCoLC)fst00898894 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical industry. |
Source of heading or term |
fast |
Authority record control number or standard number |
(OCoLC)fst01060129 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Woodhead Publishing series in biomedicine ; |
Volume/sequential designation |
no. 37. |
International Standard Serial Number |
2050-0289 |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
copycat |
d |
2 |
e |
epcn |
f |
20 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |